Meddenovo Drug Design
Meddenovo is an AI company pioneering the design of next-generation peptide therapeutics. Our platform creates novel cyclic peptides from scratch, combining advanced artificial intelligence with deep molecular understanding. These molecules can reach complex targets that small molecules or antibodies cannot, offering new possibilities for treating cancer and other diseases. We bring together science, computation, and creativity to design precise, stable, and effective candidates within weeks instead of months. Our technology is already being applied in collaboration with leading pharmaceutical partners to accelerate discovery and reduce development risk. Meddenovo’s mission is to make intelligent drug design accessible to every scientist, turning complex discovery processes into simple, insightful decisions that bring better medicines to patients faster.
Tech Stack (7 technologies)
Frequently Asked Questions
What technologies does Meddenovo Drug Design use?+
Meddenovo Drug Design uses 7 technologies including Bootstrap, Fastly, GitHub Pages.
What industry is Meddenovo Drug Design in?+
Meddenovo Drug Design operates in the Artificial Intelligence (AI) industry.
Where is Meddenovo Drug Design based?+
Meddenovo Drug Design is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026